The nucleotide sequence of the gene to the left of the gI gene of equine herpesvirus 4 (EHV-4) was determined. The gene encodes a peptide of 402 amino acids with an unprocessed M r of 45 323. The predicted polypeptide has several features of a glycoprotein including a hydrophobic signal sequence, a membrane spanning domain and four potential N-linked glycosylation sites within the proposed external domain. The predicted amino acid sequence of EHV-4 gD shows 83 % identity with that of equine herpesvirus 1 gD. Conservation of the tertiary structure is suggested by the alignment of six cysteine residues with those of the gD of six other alphaherpesviruses. Screening a 2gtl 1/EHV-4 expression library with monoclonal antibodies against several of the most abundant EHV-4 glycoproteins unequivocally identified the protein encoded by the EHV-4 gD gene as gp17/18.
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Equine herpesvirus 4 (EHV-4), a member of the alphaherpesvirus group, is closely related antigenically (Burrows & Goodridge, 1973) and genetically (Cullinane et al., 1988) to the more virulent equine herpesvirus 1 (EHV-1). EHV-1, a respiratory pathogen, is a major cause of abortion and neurological disease in horses. EHV-4 is more frequently isolated from cases of respiratory disease than EHV-1 but it is rarely associated with abortion or with neurological disease (Allen & Bryans, 1986; Meyer et al., 1987) . At present it is not possible to distinguish between infections by the two viruses by serological examination, but virus isolates can be distinguished by their growth characteristics in tissue culture (Burrows & Goodridge, 1973) , and more definitively by screening with monoclonal antibodies (Yeargan et al., 1985) or by restriction endonuclease analysis of their DNAs (Sabine et al., 1981) . Although there is a fairly effective vaccine available against EHV-1 abortion (reviewed by Allen & Bryans, 1986) , current vaccines against respiratory disease associated with either EHV-1 or EHV-4 do not appear to offer a satisfactory level of protection. Despite vaccination and good husbandry programmes, respiratory disease associated with EHV-4, and to a lesser extent EHV-1, causes significant financial loss to the racing industry each year.
The virions of EHV-1 and EHV-4 contain six 'high abundance glycoproteins' (virion polypeptides that are metabolically labelled with [SH] glucosamine and appear in high relative abundance in Coomassie blue-stained SDS-PAGE gels) in addition to several minor glycoproteins (Turtinen & Allen, 1982; Turtinen et al., 1981) . The six high abundance glycoproteins are designated gp2, gpl0, gpl3, gpl4, gp17/18 and gp21/22. The EHV-1 proteins have respective apparent Mrs by SDS-PAGE gel analysis of 190K to 240K, 124K, 96K, 90K, 68K/63K and 45K/41K/39K and their EHV-4 counterparts have respective apparent Mrs of 190K to 240K, 124K, 110K, 87K, 68K/61K and 45K/41K/39K (Allen & Bryans, 1986) . Amino acid sequence homology between EHV-1 glycoproteins and those of EHV-4 with identical designations has been established by antigenic cross-reactivity with monoclonal antibodies (Crabb et al., 1991) . Allen & Yeargan (1987) localized the genes that encode the major EHV-1 glycoproteins by screening an EHV-1/2gtl 1 expression library with monoclonal antibodies specific to the individual proteins. Two glycoproteins, gpl3 and gpl4, mapped to positions collinear with herpes simplex virus (HSV) genes that encode glycoproteins gC and gB. EHV-1 gp2, gpl0 and gp21/22a mapped to positions in the long unique region that are not collinear with known glycoprotein genes in other alphaherpesviruses. The gene encoding gpl0 was identified by determining the DNA sequence of the 2gt 11 insert containing the gpl0 epitope (Whittaker et al., 1991) . The insert was closely similar to an EHV-4 open reading frame (ORF) designated B6 which encodes the homologue of HSV-1 VP13/14, a tegument protein.
One of the major EHV-1 glycoproteins, gp17/18, mapped to a region of the short unique component which contains genes encoding the homologues of HSV-1 glycoproteins gE, gI and gD. Recently, EHV-1 gp17/18 was identified as the homologue of HSV-1 gD (Elton et al., 1992) . Part of EHV-1 gD was expressed in a plasmid vector and was shown to react with the monoclonal antibody used to map gp17/18. The DNA sequence of EHV-1 gD was determined by Audonnet et al. (1990) Of the six high abundance glycoproteins identified by Turtinen et al. (1981) in EHV-4 virions, the DNA sequences of gpl3 (Nicolson & Onions, 1990) , gpl4 (Riggio et al., 1989) and gpl0 (Whittaker et al., 1991) have been determined. Other EHV-4 glycoprotein genes which have been sequenced include the homologues of HSV-1 gH (Nicolson et al., 1990) , gE and gI (Cullinane et al., 1988; J. Neilan et al., unpublished) and gG (Crabb et al., 1992) . In this communication we present the DNA sequence of the EHV-4 homologue of HSV-1 gD and identify EHV-4 gD as gp17/18.
Determination of the nucleotide sequence of the 3 kbp EcoRI/BamHI fragment to the left of BamHI l ( Fig. 1 ) revealed the presence of part of a gene upstream from the gI gene (J. Neilan et al., unpublished) . To determine the DNA sequence of the remainder of this gene, the 1.5 kbp HindIII/EcoRI fragment adjacent to EcoRI j was inserted into plasmid vector pGEM-7Zf(+) (Promega). Random 400 to 800 bp fragments of DNA insert were generated by sonication, repaired with T4 DNA polymerase and electroeluted from a 1.2 % SeaPlaque agarose gel. The purified DNA was ligated into the SmaI site of bacteriophage M13mp18 DNA. Recombinants were sequenced by the dideoxynucleotide chain termination method using [35S]dATP (Amersham, SJ.1304). The sequencing reactions were analysed in 6% polyacrylamide wedge gels. The data were manipulated and analysed using a DEC MicroVax II using programs described by Staden (1982) . Amino acid sequence comparisons were carried out using the GCG Sequence Analysis Software Package (Devereux et al., 1984) .
The nucleotide sequence of the gene upstream from gI shown in Fig. 2 starts 291 nucleotides from the proposed initiation codon and ends at the stop codon. Each nucleotide was determined an average of eight times and the entire sequence was determined on both strands.
Analysis of the predicted amino acid sequence of the ORF indicated similarity to HSV-1 gD (McGeoch et al., 1985) and to its EHV-1 counterpart (Audonnet et al., 1990; Flowers et at., 1991 ; Whalley et at., 1991 ; Telford et al., 1992) . Therefore the region containing this ORF is referred to as the EHV-4 gD gene.
In addition to the proposed initiation codon at nucleotides 292 to 294, there are in-frame ATG codons located at nucleotides 310 to 312, 313 to 315 and 361 to 363. The proposed start codon has a purine at position -3, the most highly conserved feature of Kozak's consensus sequence CC(~)CCATGG (Kozak, 1983) . Assignment of this codon as the initiation codon is supported by the fact that it is the first ATG in the ORF, the DNA immediately downstream encodes a putative signal sequence (see below) and that it aligns with the ATG of EHV-1 gD which best fits Kozak's model. Potential transcriptional regulatory sequences are located upstream from the ORF: a TATA box (Corden et al., 1980) at positions 193 to 196 and a CAAT box (Benoist et al., 1980) at positions 136 to 139. An AT-rich motif (AAAAATTAT) similar to one shown to function as a TATA element of HSV gD (Everett, 1984) is located eight nucleotides downstream of the putative TATA box. The nucleotide sequence of the putative EHV-4 gD TATA box and the AT-rich motif are identical to those identified upstream of the EHV-1 gD ORF (Flowers et al., 1991) . In addition a sequence showing similarity to the consensus recognition sequence for the binding of the IE175 protein to the gD promoter of HSV-1 (Tedder et al., 1989) , located 134 nucleotides upstream of the TATA box of EHV-4 gD, is similar in sequence and location to that identified in EHV-1 (Flowers et al., 1991) .
The sequence downstream of the EHV-4 gD ORF does not include a polyadenylation sequence of con- 
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CAAAAAAACCACCAGCGTCT~TAGC~CTCTACGTTTATTGGAGTTGTTAT~GTTTGGGTGT~TTGGCTTGATATCAGTTGGAG~AATTTTATACGT 1400 2>>> CWRRRKSQNKSEKNGSPSLRSTFKDVKYTQLP-402 T~TTG~GT~G~GA~GTCACAG~C~GTCTGAAAAAAATGGCTCACCTAGCCTACGCTCTACCTTT~GGAT~TCAAATATA~TCAGCTTCCGT~ 1500 sensus AATAAA (Proudfoot & Brownlee, 1976) . Similarly, no such signal sequence was identified downstream of the gD gene of the Kentucky D strain of EHV-1 (Audonnet et al., 1990) , the HVS 25A strain (Whalley et al., 1991) or the Ab4p strain (Telford et al., 1992) . A putative polyadenylation sequence was identified by Flowers et al. (1991) 12 nucleotides downstream from the stop codon of the gD gene of the Kentucky A strain of EHV-1. However, this hamster-adapted strain has a frameshift mutation at the C terminus of the gD gene and a major deletion downstream of the gene which has resulted in the loss of three genes (Telford et al., 1992) . No polyadenylation signal was identified immediately downstream of the gD gene of HSV-1 (McGeoch et al., 1985) , HSV-2 (McGeoch et al., 1987) , pseudorabies virus (PRV) (Petrovskis et al., 1986 ) and Marek's disease virus (MDV) (Ross et al., 1991) . The HSV-1 gD transcript is 3' coterminal with the transcript of the next gene downstream, which encodes gI, and the PRV gp50 (the gD counterpart) transcript appears to be coterminal with the next downstream gene (Kost et al., 1989) . This coterminal arrangement is likely, then, to apply also to EHV-4, EHV-1 and MDV. The EHV-40RF starting at the ATG at nucleotides 292 to 294 encodes a polypeptide of 402 amino acids (aa) with an unprocessed M r of 45 323. This size is comparable to that of EHV-1 gD (402 aa, Audonnet et al., 1990; 385 aa, Flowers et al., 1991 ; 402 aa, Whalley et al., 1991 ; 452 aa, Telford et al., 1992) , HSV-1 gD (394 aa, Watson et al., 1982; McGeoch et al., 1985) , HSV-2 gD (393 aa; McGeoch et al., 1987) , PRV gp50 (402 aa; Petrovskis et al., 1986) , MDV gD (398 aa; Ross et al., 1991) and bovine herpesvirus 1 (BHV-1) gD (417 aa; Tikoo et al., 1990) . The predicted polypeptide shares several features of a glycoprotein sequence with these proteins. A stretch of hydrophobic amino acids within the extreme N- Fig. 3 . Comparison of gD of EHV-4 (residues 88 to 266), EHV-1 (residues 88 to 266), BHV-1 (residues 75 to 255), PRV (residues 65 to 246), MDV (residues 83 to 259), HSV-1 (residues 90 to 269) and HS¥-2 (residues 90 to 269) displaying the region of highest similarity between their amino acid sequences.
terminal region of the polypeptide corresponds to a signal sequence (Fig. 2) . Using the criteria of von Heijne (1986) for the prediction of signal sequence cleavage sites, cleavage is predicted to occur after the serine residue, amino acid 26. Thus, the cleaved signal peptide is expected to be 26 amino acids long which is similar in size to that of the predicted signal peptides of EHV-1 gD (26 aa; Flowers et al., 1991; Audonnet et al., 1990; Whalley et al., 1991), HSV-1 gD (25 aa; Watson et al., 1982) and MDV gD (25 aa; Ross et al., 1991) . The predicted signal peptides of PRV gD (18 aa; Petrovskis et al., 1986) and BHV-1 gD (18 aa; Tikoo et al., 1990) are slightly shorter. The hydrophobic sequence near the carboxy terminus (residues 349 to 372) is a potential transmembrane domain, and a potential cytoplasmic domain stretches from amino acids 372 to 402. Residues 26 to 349 are predicted to constitute the external domain which projects from the surface of mature virions and infected cell membranes and comprises the glycosylated portion of the polypeptide. Within this region there are four putative N-linked glycosylation sites (Fig. 2) . The predicted amino acid sequence of EHV-4 gD was compared with that of other alphaherpesviruses. EHV-4 gD shares 83 % sequence identity with EHV-I gD, 38 % with BHV-1 gD, 34% with PRV gD, 29% with MDV gD, 25 % with HSV-1 gD and 24 % with HSV-2 gD. The alignment of the most highly conserved region in the gD family is shown in Fig. 3 . Conservation of the tertiary structure is suggested by the fact that six cysteines are aligned in the seven proteins. They are in the 1-3-2 pattern described by McGeoch (1990) in HSV-1 gD, gG and gI and their counterparts in HSV-2, PRV and varicella-zoster virus. The four potential N-linked glycosylation sites in EHV-4 gD are conserved in EHV-1 gD but are not conserved in HSV-1 gD, HSV-2 gD, BHV-1 gD or MDV gD. PRV gp50 is unusual in that it has no such sites (Petrovskis et al., 1986) . Also, the alternating of proline and arginine residues on the external domain of gp50 which has been suggested may produce a rigid hydrophilic structure (Petrovskis et al., 1986) is not a feature of EHV-4 gD or of the other gD homologues sequenced to date.
The 2gtl 1 expression vector system of Young & Davis (1983) was used to identify the glycoprotein encoded by the EHV-4 gD gene. Random 200 to 400 bp fragments of EHV-4 DNA were generated by sonication, blunt-ended by treating with S1 nuclease and T4 DNA polymerase, methylated and attached to EcoRI linkers. They were ligated to 2gtl 1 DNA and packaged in vitro into phage heads (Promega). They were plated on Y1090 cells (Promega) and overlaid with IPTG-treated nitrocellulose filters. The filters were screened with monoclonal antibodies against several of the most abundant gtycoproteins and then incubated with rabbit anti-mouse IgG. Immunopositive phage were detected using BCIP/NBT colour development substrate (Promega).
A non-neutralizing monoclonal antibody (20C4) against EHV-4 gp17/18 (Yeargan et al., 1985) detected two positive recombinants in a population of 200000 phage. These were plaque-purified and rescreened until homogeneously positive. The EHV-4 inserts were recloned into M13mpl8 for DNA sequencing. DNA sequence analysis revealed that the two recombinants contain overlapping sequences from the gD gene (Fig. 2) . This unequivocally identifies EHV-4 gp17/18 as the homologue of HSV-1 gD.
One of the recombinants encodes 174 amino acids in the external domain. The other encodes 92 amino acids in the C terminus of the external domain, the hydrophobic transmembrane domain and most of the cytoplasmic domain. The external domain of the protein projects from the virion envelope or infected cell membrane and is likely to contain the major antigenic determinants. The antigenic domain reactive with the monoclonal antibody must be contained within the 22 amino acid sequence in the external domain which is encoded by both recombinants. Nineteen of the 22 shared amino acids are identical in EHV-l gD (Audonnet et al., 1990; Whalley et al., 1991; Telford et al., 1992) (Fig. 2) . This observation is consistent with the antigenic cross-reactivity between EHV-1 and EHV-4 gDs when tested in Western blot assays with monoclonal antibody 20C4 (data not shown). Predictive computer analysis, monoclonal antibodies and synthetic peptides have been used extensively to map the epitopes of HSV-1 gD (Eisenberg et al., 1985; Strynadka et al., 1988; Muggeridge et al., 1990) . No data concerning the epitopes of EHV-4 gD have been published to date. The 2gtll/EHV-4 library in combination with monoclonal antibodies could be employed to identify linear antigenic determinants of EHV-4 gD prior to the localization of epitopes using synthetic peptides. Because of the very close relationship of EHV-I and EHV-4 (83% aa sequence identity) it is likely that the majority of the epitopes will be cross-reactive. Little is known about the immunogenicity of EHV-4 gp17/18, but a monoclonal antibody against EHV-1 gp17/18 confers passive protection to hamsters against challenge with homologous virus (Stokes et al., 1989 ) and a neutralizing epitope has been mapped in the gD of the hamster-adapted EHV-1 strain, KyA (Flowers & O'Callaghan, 1992) . The HSV-1 and HSV-2 gD are 85 % identical and vaccination with either confers cross-protection against the heterologous virus in the mouse model (Long et al., 1984) . Given the similarity of EHV-1 gD and EHV-4 gD it seems reasonable to suggest that vaccination with either may induce cross-protection against heterologous virus. Thus this protein is a good candidate for immunogenicity studies with a view to inclusion in a subunit vaccine.
